RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; October 2017, Vol. 5 Issue: 10 p785-794, 10p
- Subject
- Language
- ISSN
- 22132600; 22132619